Logo image of DRMA

DERMATA THERAPEUTICS INC (DRMA) Stock Analyst Ratings

NASDAQ:DRMA - US2498454055 - Common Stock

5.83 USD
+0.35 (+6.39%)
Last: 8/25/2025, 8:15:27 PM
6.267 USD
+0.44 (+7.5%)
After Hours: 8/25/2025, 8:15:27 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to DRMA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.2. This target is 74.96% above the current price.
DRMA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DRMA.
In the previous month the buy percentage consensus was at a similar level.
DRMA was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

DRMA Historical Analyst RatingsDRMA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -46 -42 -38 -34 -30 -26 -22 -18 -14 -10 -6 -2 2 4 6

Price Target & Forecast

Price Low Median Mean High 5.8310.1010.2010.2010.50 - 73.24% 74.96% 74.96% 80.10%

Related screens

DRMA Current Analyst RatingDRMA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-08-21 Maxim Group Maintains Buy -> Buy
2025-05-21 Maxim Group Maintains Buy -> Buy
2024-08-21 Maxim Group Maintains Buy -> Buy
2023-03-23 Maxim Group Maintains Buy
2021-09-21 Brookline Capital Initiate Buy
2021-09-14 Maxim Group Initiate Buy